Latest Insider Transactions at Medpace Holdings, Inc. (MEDP)
This section provides a real-time view of insider transactions for Medpace Holdings, Inc. (MEDP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medpace Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medpace Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 26
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+29.54%
|
$900,000
$90.65 P/Share
|
|
Sep 03
2021
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$390,000
$195.0 P/Share
|
|
Sep 03
2021
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$108,000
$54.99 P/Share
|
|
Sep 03
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
604
-0.01%
|
$115,364
$191.82 P/Share
|
|
Sep 03
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
604
-0.01%
|
$115,364
$191.82 P/Share
|
|
Sep 03
2021
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
7,185
-48.0%
|
$1,379,520
$192.67 P/Share
|
|
Sep 02
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
30,234
-0.5%
|
$5,774,694
$191.85 P/Share
|
|
Sep 02
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,234
-0.5%
|
$5,774,694
$191.85 P/Share
|
|
Sep 02
2021
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
55,037
-78.62%
|
$10,567,104
$192.16 P/Share
|
|
Sep 01
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,304
-0.24%
|
$2,660,544
$186.29 P/Share
|
|
Sep 01
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
14,304
-0.24%
|
$2,660,544
$186.29 P/Share
|
|
Aug 31
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,675
-0.21%
|
$2,306,850
$182.04 P/Share
|
|
Aug 31
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
12,675
-0.21%
|
$2,306,850
$182.04 P/Share
|
|
Aug 30
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,236
-0.2%
|
$2,239,188
$183.14 P/Share
|
|
Aug 30
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
12,236
-0.2%
|
$2,239,188
$183.14 P/Share
|
|
Aug 27
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,840
-0.2%
|
$2,143,040
$181.83 P/Share
|
|
Aug 27
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
11,840
-0.2%
|
$2,143,040
$181.83 P/Share
|
|
Aug 26
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
466
-0.01%
|
$83,880
$180.17 P/Share
|
|
Aug 26
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
466
-0.01%
|
$83,880
$180.17 P/Share
|
|
Aug 25
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
7,622
-0.13%
|
$1,371,960
$180.54 P/Share
|
|
Aug 25
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,622
-0.13%
|
$1,371,960
$180.54 P/Share
|
|
Aug 24
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
1,814
-0.03%
|
$326,520
$180.06 P/Share
|
|
Aug 24
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,814
-0.03%
|
$326,520
$180.06 P/Share
|
|
Aug 23
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
1,482
-0.02%
|
$266,760
$180.22 P/Share
|
|
Aug 23
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,482
-0.02%
|
$266,760
$180.22 P/Share
|
|
Aug 18
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,301
-0.04%
|
$414,180
$180.49 P/Share
|
|
Aug 18
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
2,301
-0.04%
|
$414,180
$180.49 P/Share
|
|
Aug 17
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
5,246
-0.09%
|
$954,772
$182.1 P/Share
|
|
Aug 17
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,246
-0.09%
|
$954,772
$182.1 P/Share
|
|
Aug 16
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
16,817
-0.28%
|
$3,060,694
$182.83 P/Share
|
|
Aug 16
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
16,817
-0.28%
|
$3,060,694
$182.83 P/Share
|
|
Aug 05
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
556
-0.01%
|
$100,080
$180.04 P/Share
|
|
Aug 05
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
556
-0.01%
|
$100,080
$180.04 P/Share
|
|
Aug 04
2021
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$178,000
$178.0 P/Share
|
|
Aug 04
2021
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$54,000
$54.99 P/Share
|
|
Jul 29
2021
|
Tom C King Director |
SELL
Open market or private sale
|
Direct |
226
-45.2%
|
$39,550
$175.74 P/Share
|
|
Jul 29
2021
|
Tom C King Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$37,500
$75.63 P/Share
|
|
Jul 27
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
131
-0.0%
|
$23,580
$180.93 P/Share
|
|
Jul 27
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
131
-0.0%
|
$23,580
$180.93 P/Share
|
|
Jul 26
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,209
-0.25%
|
$2,752,829
$181.47 P/Share
|
|
Jul 26
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
15,209
-0.25%
|
$2,752,829
$181.47 P/Share
|
|
Jul 23
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
18,882
-0.31%
|
$3,417,642
$181.21 P/Share
|
|
Jul 23
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
18,882
-0.31%
|
$3,417,642
$181.21 P/Share
|
|
Jul 22
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,516
-0.14%
|
$1,532,880
$180.63 P/Share
|
|
Jul 22
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
8,516
-0.14%
|
$1,532,880
$180.63 P/Share
|
|
Jul 21
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,206
-0.15%
|
$1,675,492
$182.42 P/Share
|
|
Jul 21
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
9,206
-0.15%
|
$1,675,492
$182.42 P/Share
|
|
Jul 20
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,176
-0.17%
|
$1,862,208
$183.06 P/Share
|
|
Jul 20
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
10,176
-0.17%
|
$1,862,208
$183.06 P/Share
|
|
Jul 19
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,442
-0.02%
|
$261,002
$181.11 P/Share
|